How to make accessible for practice new diagnostic approaches created by science

09.00 HOW TO MAKE ACCESSIBLE FOR PRACTICE NEW DIAGNOSTIC APPROACHES CREATED BY SCIENCE

Seminars with WHO EXPERTS Chairman: Dr Yana I. Gurkovskaya & Dr Farkhad Shamilov, Petrovax

09.00 Influence of polyoxidonium (immune adjuvant) on primary tumor and bone marrow in breast cancer patients. Chairman: Dr Maria.E. Ilatovskaya

09.30 Perspectives of CTC and DTC HER2 detection for therapeutic targeting: questions and concerns.

Скачать доклад

10.00 Coffee break

Chairman: Prof Nikolay N.Tupitsyn, Moscow, Russia & Lubov Kuprova, Bioline

10.30 8-color Euroflow panels in MRD diagnosis in leukemias and lymphomas. Chairmen: Prof Piarvin A. Zeynalova, Prof Timur T. Valiev & Mobil Akhmedov

Скачать доклад

11.00 CD20 in B-cell lymphomas: diagnosis and treatment of MRD. Immunochemotherapy with rituximab for pediatric patients with 3-4 Burkitt lymphoma risk group. Timur Valiev, Moscow, Russia

Скачать доклад

11.30 YOUNG SCIENTIST SELECTED ORAL PRESENTATIONS

11.30 Antigen expression heterogenicity used for MRD monitoring in B-lymphoblastic leukemia. Kateryna Vilchevska, Donetsk, Ukraine

Скачать доклад

11.40 Possibilities of overcoming drug resistance of blast cells in children with relapse of acute lymphoblastic leukemia. Natalia Batmanova, Moscow, Russia

Скачать доклад

11.50 Hospicell, a subset of bone marrow stromal cell regulate ATP-binding cassette gene expression via insulin-like growth factor-I in a leukemia cell line. Nadia Benabou, Paris, France

12.00 Role of telomerase mutation on myelodysplastic syndrome and other haematopoietic disorders. Sushama Jose Shyam, Brno, Czech Republic

Скачать доклад

12.10 Take home message.